FourThought Financial’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

FourThought Financial’s Portfolio STAB Stock Details STAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$0	Hold	125	–	–	﹤0.01%	1593
2022 Q2	$0	Hold	125	–	–	﹤0.01%	1590
2022 Q1	$0	Hold	125	–	–	﹤0.01%	1603
2021 Q4	$0	Hold	125	–	–	﹤0.01%	1607
2021 Q3	$1K	Hold	125	–	–	﹤0.01%	1546
2021 Q2	$1K	Hold	125	–	–	﹤0.01%	1523
2021 Q1	$1K	Hold	125	–	–	﹤0.01%	1497
2020 Q4	$1K	Buy	+125	New	+$356	﹤0.01%	1490

Other funds holding STAB

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

FourThought Financial's STAB Position: Q3 2022 in Review

FourThought Financial held its Statera Biopharma, Inc. Common Stock (STAB) position steady in Q3 2022 at 125 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1593.

FourThought Financial first reported a position in STAB in Q4 2020 and has held it in 8 quarters since. The position peaked at $1K in Q3 2021. 35 funds tracked by Wall St. Rank hold STAB as of Q3 2022.

FourThought Financial held 125 shares of Statera Biopharma, Inc. Common Stock worth $0 as of Q3 2022.
FourThought Financial left its Statera Biopharma, Inc. Common Stock share count unchanged in Q3 2022.
Statera Biopharma, Inc. Common Stock made up ﹤0.01% of FourThought Financial's portfolio in Q3 2022, its #1593 holding.
FourThought Financial first reported a position in Statera Biopharma, Inc. Common Stock in Q4 2020 and has held it in 8 quarters since.
FourThought Financial's Statera Biopharma, Inc. Common Stock position peaked at $1K in Q3 2021.
35 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.